Andreas Karas

Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila et al. · The Lancet Infectious Diseases · 2017 · 219 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +14

A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections

Wolfgang Knitsch, Jean‐Louis Vincent, Stefan Utzolino et al. · Clinical Infectious Diseases · 2015 · 99 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

Pharmacy, Pharmacoeconomics, Antimicrobial Resistance +12

Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread

David W. Eyre, Kerrie Davies, Warren N. Fawley et al. · Clinical Infectious Diseases · 2018 · 83 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Global phylogeography and evolutionary history of Shigella dysenteriae type 1

Elisabeth Njamkepo, Nizar Fawal, Alicia Tran-Dien et al. · Nature Microbiology · 2016 · 78 citations · Full text

Life Sciences, Evolutionary Biology, Microbiology +16